{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:56:08Z","timestamp":1781078168966,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04077-7","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:01:22Z","timestamp":1715652082000},"page":"3123-3132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of incremental peritoneal dialysis with low glucose-degradation product neutral pH solution on clinical outcomes"],"prefix":"10.1007","volume":"56","author":[{"given":"Hasan Haci","family":"Yeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Altunok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Cankaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Bakirdogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadim","family":"Ako\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesudiye","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuncay","family":"Sahutoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arda","family":"Erdut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ozkahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yener","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Tunca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekrem","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcge","family":"Erek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin","family":"Akagun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galip","family":"Guz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,14]]},"reference":[{"key":"4077_CR1","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1681\/ASN.V86965","volume":"8","author":"DN Churchill","year":"1997","unstructured":"Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR (1997) Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 8:965\u2013971","journal-title":"J Am Soc Nephrol"},{"key":"4077_CR2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1681\/ASN.V1351307","volume":"13","author":"R Paniagua","year":"2002","unstructured":"Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Group MNCS (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307\u20131320","journal-title":"J Am Soc Nephrol"},{"key":"4077_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0272-6386(03)00362-7","volume":"41","author":"F Termorshuizen","year":"2003","unstructured":"Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT (2003) The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 41:1293\u20131302","journal-title":"Am J Kidney Dis"},{"key":"4077_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.34067\/KID.0006902022","volume":"4","author":"A Fernandes","year":"2023","unstructured":"Fernandes A, Matias P, Branco P (2023) Incremental peritoneal dialysis\u2014definition, prescription, and clinical outcomes. Kidney360 4:272\u2013277","journal-title":"Kidney360"},{"key":"4077_CR5","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/S0272-6386(97)70028-3","volume":"30","author":"T Golper","year":"1997","unstructured":"Golper T, Churchill D, Burkart J, Firanek C, Geary D, Gotch F, Moore L, Nolph K, Powe N, Singh H (1997) NKF DOQI clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 30:S67-136","journal-title":"Am J Kidney Dis"},{"key":"4077_CR6","first-page":"355","volume-title":"Incremental peritoneal dialysis: incremental gains","author":"A Dhoot","year":"2023","unstructured":"Dhoot A, Brown EA, Robinson B, Perl J (2023) Incremental peritoneal dialysis: incremental gains. SAGE Publications, London, pp 355\u2013358"},{"key":"4077_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0896860819895364","volume":"40","author":"EA Brown","year":"2020","unstructured":"Brown EA, Blake PG, Boudville N, Davies S, de Arteaga J, Dong J, Finkelstein F, Foo M, Hurst H, Johnson DW (2020) International society for peritoneal dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int 40:244\u2013253","journal-title":"Perit Dial Int"},{"key":"4077_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ekir.2021.11.019","volume":"7","author":"MS Cheetham","year":"2022","unstructured":"Cheetham MS, Cho Y, Krishnasamy R, Jain AK, Boudville N, Johnson DW, Huang LL (2022) Incremental versus standard (full-dose) peritoneal dialysis. Kidney Int Rep 7:165\u2013176","journal-title":"Kidney Int Rep"},{"key":"4077_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/sdi.12712","volume":"31","author":"BL Auguste","year":"2018","unstructured":"Auguste BL, Bargman JM (2018) Incremental peritoneal dialysis: new ideas about an old approach. Semin Dial 31:445\u2013448","journal-title":"Semin Dial"},{"key":"4077_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/089686088700700306","volume":"7","author":"KO Nolph","year":"1987","unstructured":"Nolph KO, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP (1987) Peritoneal equilibration test. Perit Dial Int 7:138\u2013148","journal-title":"Perit Dial Int"},{"issue":"2","key":"4077_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","volume":"42","author":"PKT Li","year":"2022","unstructured":"Li PKT, Chow KM, Cho Y et al (2022) ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int 42(2):110\u2013153","journal-title":"Perit Dial Int"},{"key":"4077_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/08968608231175826","author":"A Hayat","year":"2023","unstructured":"Hayat A, Cho Y, Hawley CM, Htay H, Krishnasamy R, Pascoe E, Teitelbaum I, Varnfield M, Johnson DW (2023) Association of incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: the balANZ trial. Perit Dial Int. https:\/\/doi.org\/10.1177\/08968608231175826","journal-title":"Perit Dial Int"},{"key":"4077_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/08968608231195517","volume":"43","author":"MS Cheetham","year":"2023","unstructured":"Cheetham MS, Cho Y, Krishnasamy R, Milanzi E, Chow J, Hawley C, Moodie J-A, Jose MD, MacGinley R, Nguyen T (2023) Multicentre registry analysis of incremental peritoneal dialysis incidence and associations with patient outcomes. Perit Dial Int 43:383\u2013394","journal-title":"Perit Dial Int"},{"key":"4077_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s40620-016-0344-z","volume":"29","author":"M Sandrini","year":"2016","unstructured":"Sandrini M, Vizzardi V, Valerio F, Ravera S, Manili L, Zubani R, Lucca BJ, Cancarini G (2016) Incremental peritoneal dialysis: a 10 year single-centre experience. J Nephrol 29:871\u2013879","journal-title":"J Nephrol"},{"key":"4077_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10047-005-0290-3","volume":"8","author":"T Tomo","year":"2005","unstructured":"Tomo T, Okabe E, Matsuyama K, Iwashita T, Yufu K, Nasu M (2005) The effect of peritoneal rest in combination therapy of peritoneal dialysis and hemodialysis: using the cultured human peritoneal mesothelial cell model. J Artif Organs 8:125\u2013129","journal-title":"J Artif Organs"},{"key":"4077_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10047-020-01215-7","volume":"24","author":"A Ueda","year":"2021","unstructured":"Ueda A, Nagai K, Yamagata K (2021) Preserved peritoneal function by short-term two-day peritoneal rest in hemodialysis combination therapy patients. J Artif Organs 24:296\u2013300","journal-title":"J Artif Organs"},{"key":"4077_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/ijn.ijn_242_23","volume":"33","author":"IM Alrowiyti","year":"2023","unstructured":"Alrowiyti IM, Bargman J (2023) A review of residual kidney function in peritoneal dialysis patients. Indian J Nephrol 33:239\u2013246","journal-title":"Indian J Nephrol"},{"key":"4077_CR18","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/ndt\/16.11.2207","volume":"16","author":"MK Menon","year":"2001","unstructured":"Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transpl 16:2207\u20132213","journal-title":"Nephrol Dial Transpl"},{"key":"4077_CR19","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1097\/01.ASN.0000135053.98172.D6","volume":"15","author":"AY-M Wang","year":"2004","unstructured":"Wang AY-M, Wang M, Woo J, Lam CW-K, Lui S-F, Li PK-T, Sanderson JE (2004) Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 15:2186\u20132194","journal-title":"J Am Soc Nephrol"},{"key":"4077_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.krcp.2014.01.001","volume":"33","author":"H Rhee","year":"2014","unstructured":"Rhee H, Yang JY, Jung WJ, Shin MJ, Yang BY, Song SH, Kwak IS, Seong EY (2014) Significance of residual renal function for phosphate control in chronic hemodialysis patients. Kidney Res Clin Pract 33:58\u201364","journal-title":"Kidney Res Clin Pract"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04077-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04077-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:34:55Z","timestamp":1723563295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04077-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["4077"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04077-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The design and procedures of the study were approved by the Ethics Committee of the University and Turkish Pharmaceuticals and Medical Devices Agency in agreement with the principles of the Declaration of Helsinki and ethical standards for human experimentation (Date:18\/04\/2022, No:331\/Date: 08\/09\/2022 No: 88521274, respectively).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}